OncLiveDr. Rosenberg on Immunotherapy in Non-Metastatic Muscle Invasive Bladder CancerOncLiveJonathan E. Rosenberg, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses immunotherapy in non-metastatic muscle-invasive bladder canc… Continue reading
Business Insider |
Pharma giant Bristol-Myers Squibb just made another big bet on cancer immunotherapy
Business Insider Bristol-Myers has two drugs, Opdivo and Yervoy, that are a part of a new class of cancer treatments called cancer immunotherapy that harness the body’s immune system to go after cancer. Unlike chemotherapy, which involves administering powerful drugs … IFM Gets $300M Bristol Buyout, Plans Second Strike With New SpinoutXconomy |
|
Behind The Hype, Crispr Is A Story Of Slow Progress And Acrimony
Seeking Alpha Some people reading this morning’s mainstream press headlines about a Nature paper describing the correction of a germline mutation using Crispr (NASDAQ:CRSP) might be excused for thinking that we are entering a Gattaca-like world of designer babies. Trading Spotlight on Crispr Therapeutics AG (CRSP) SharesBenton Bulletin Marathon Asset Management Llp Boosted Compania De Minas Buenaventura (BVN) Holding; Crispr Therapeutics AG …FlintDaily.com |
|
Boy undergoes stem cell therapy for autism
Times of India Udaipur: A seven-year-old boy, resident of Udaipur, underwent stem cell therapy in a Mumbai’s private hospital for treatment of Attention Deficit Hyperactive Disorder (Autism). “Stem cell therapy is emerging as one of the newer treatment options for … |